Hans-Joachim Knölker
Corporate Officer/Principal bei Hanover College
Profil
Hans-Joachim Knölker is the founder of JADO Technologies GmbH, which was founded in 2001.
Currently, he is a Professor at Hanover College since 1990.
In the past, he worked as the Chairman-Chemistry Department at the University of Karlsruhe from 1995 to 1997 and as a Professor-Organic Chemistry at Dresden University of Technology from 2000 to 2012.
Aktive Positionen von Hans-Joachim Knölker
| Unternehmen | Position | Beginn |
|---|---|---|
| Hanover College | Corporate Officer/Principal | 01.01.1990 |
Ehemalige bekannte Positionen von Hans-Joachim Knölker
| Unternehmen | Position | Ende |
|---|---|---|
JADO Technologies GmbH
 JADO Technologies GmbH Drugstore ChainsRetail Trade JADO Technologies GmbH develops novel small molecule drugs. It offers drugs based on an unrivalled insight into cell membrane biology and the role of specific cellular domains, including lipid rafts. The firm's technology provides an insight into diverse pathological mechanisms and drives the design of innovative drugs with new modes of action. The company was founded by Teymuras Kurzchalia, Hans-Joachim Knölker, Gary Jennings, Kai Simons and Marino Zerial in 2001 and is headquartered in Dresden, Germany. | Gründer | 17.04.2014 |
| Dresden University of Technology | Corporate Officer/Principal | - |
| University of Karlsruhe | Direktor/Vorstandsmitglied | 01.01.1997 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 1 |
|---|---|
JADO Technologies GmbH
JADO Technologies GmbH Drugstore ChainsRetail Trade JADO Technologies GmbH develops novel small molecule drugs. It offers drugs based on an unrivalled insight into cell membrane biology and the role of specific cellular domains, including lipid rafts. The firm's technology provides an insight into diverse pathological mechanisms and drives the design of innovative drugs with new modes of action. The company was founded by Teymuras Kurzchalia, Hans-Joachim Knölker, Gary Jennings, Kai Simons and Marino Zerial in 2001 and is headquartered in Dresden, Germany. | Retail Trade |
